Detalhe da pesquisa
1.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med
; 389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407001
2.
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
Am J Hematol
; 99(4): 780-784, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357757
3.
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemia.
Pharmacoepidemiol Drug Saf
; 33(1): e5678, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609668
4.
FISH-ing for answers: Can genomic arrays add to our understanding of disease biology in low-risk chronic lymphocytic leukaemia?
Br J Haematol
; 202(5): 922-924, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37519004
5.
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?
Curr Oncol Rep
; 24(12): 1705-1713, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334220
6.
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.
Haematologica
; 106(11): 2845-2852, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054118
7.
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Biol Blood Marrow Transplant
; 24(5): 997-1004, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288821
8.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880613
9.
Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study.
Am J Hematol
; 98(3): E49-E52, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459586
10.
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
Am J Hematol
; 93(11): 1394-1401, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132965
11.
Monitoring and Management of Toxicities of Novel B Cell Signaling Agents.
Curr Oncol Rep
; 20(6): 49, 2018 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29644450
12.
Rate of major bleeding with ibrutinib versus bendamustine-rituximab in chronic lymphocytic leukemia: A population-based cohort study.
Am J Hematol
; 97(9): E332-E335, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713560
13.
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
Haematologica
; 101(5): 634-43, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869630
14.
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.
Haematologica
; 106(1): 284-287, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079693
15.
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
Transfusion
; 55(8): 2010-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25808119
16.
The CNS Relapse in T-Cell Lymphoma Index Predicts CNS Relapse in Patients with T- and NK-Cell Lymphomas.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739715
17.
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Science
; 383(6682): eadi5798, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301010
18.
MRD-directed therapy in CLL: ready for prime time?
Hematology Am Soc Hematol Educ Program
; 2023(1): 413-420, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066928
19.
Vaccination efficacy in patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 64(1): 42-56, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270021
20.
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.
Target Oncol
; 18(5): 727-734, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728835